Summary of Purpose
This is a Phase II study to assess the safety and tolerability of DM199 in acute ischemic stroke patients. The study will be randomized, placebo controlled at multiple centers.Read More →
The following dates are available for this trial. Trial information last updated on 8 February 2018.
|19 Jan 2018||18 Sep 2017||30 Apr 2019||20 Jun 2019||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- DiaMedica USA Inc. Lead